Clinical Trials Logo

Filter by:
NCT ID: NCT04524442 Completed - Clinical trials for Gastroenteropancreatic Neuroendocrine Tumors

Post-Authorization Safety Study (PASS) of LysaKare® in Adult Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients

Start date: January 27, 2021
Phase: Phase 4
Study type: Interventional

The purpose of the study is to evaluate the effect of arginine/lysine solution administration on serum potassium levels. A systematic assessment of serum potassium levels will be performed during infusion and up to 24 hours post start of infusion compared to baseline.

NCT ID: NCT04524390 Completed - Biliary Atresia Clinical Trials

Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai

EMBARK
Start date: July 8, 2021
Phase: Phase 2
Study type: Interventional

A study to evaluate the efficacy and safety of maralixibat in infants with Biliary Atresia (BA) after Hepatoportoenterostomy (HPE, also known as the Kasai procedure).

NCT ID: NCT04524286 Completed - Pregnancy Related Clinical Trials

Role of Midwifery Continuity of Care in Reducing Health Inequalities

Mi-CARE
Start date: November 6, 2020
Phase:
Study type: Observational

The impact of living in a deprived area has far reaching consequences on maternal and infant health. Studies in England show women living in deprived areas have some of the poorest experiences of care, poor birth outcomes and are 50% more likely to die of pregnancy related complications than women in the least deprived neighbourhoods. Life expectancy has also stalled for women living in the most deprived areas and the global COVID-19 pandemic has further amplified existing health inequalities. The Social Determinants of Health (SDH) are the conditions in which people are born, grow, work, live, and age, and are mostly responsible for health inequities - the unfair and avoidable differences in health seen within and between populations. Evidence shows taking action on the SDH alongside Midwifery Continuity of Care (MCC) models, improves birth outcomes and reduces health inequalities. How midwives working in MCC models in areas of high deprivation address the SDH as part of their public health and prevention role is currently not clear. There is also a lack of qualitative evidence exploring the SDH from the perspectives of women themselves. Drawing on Constructivist Grounded Theory methods, this research will take place in a low-income setting in England. Through the use of semi-structured interviews with women and midwives working in an NHS MCC model, the study will generate theory to help explain how and indeed whether midwives take action to address the SDH as part of their public health role. The study also seeks to understand the SDH impacting upon women's lives and what mechanisms exist to support or obstruct engagement with the SDH. Examining these domains will contribute to the evidence base about the impact of MCC and the public health and prevention strategy in NHS maternity services.

NCT ID: NCT04523454 Completed - Clinical trials for Diabetes Mellitus, Type 1

Contraception and Pregnancy in Diabetes Mellitus

CAPRE-DM
Start date: October 2, 2020
Phase:
Study type: Observational

This study seeks to expand upon and update this body of work. It will explore the knowledge and understanding women with diabetes have around pregnancy and conception, as well as establish how well prepared these women are for a pregnancy. Using this data, we will develop better services to inform women with diabetes about the contraception and pregnancy, as well inform the development of pre-conception counselling services for women with diabetes. If successful, we would anticipate seeing an improvement in performance in future National Diabetes in Pregnancy audits.

NCT ID: NCT04523311 Completed - Migraine Clinical Trials

An Evaluation of Brief Online Hypnosis for Migraine and Tension-type Headaches

Start date: October 27, 2020
Phase: N/A
Study type: Interventional

This study aims to conduct an initial evaluation of whether a single, online, group-based session of hypnosis followed by self-hypnosis can decrease symptoms of migraine and tension-type headaches as well as improve quality of life and perceived self-efficacy over the condition.

NCT ID: NCT04522128 Completed - Quality of Life Clinical Trials

Does Quality of Life Decline During the COVID-19 Pandemic and Can we Change Behaviour to Improve Poor Quality of Life?

Start date: May 22, 2020
Phase: N/A
Study type: Interventional

The response to COVID-19 means social isolation/distancing for the majority of the UK. This has the potential to negatively affect all domains of quality of life (QoL). QoL can be improved by giving feedback on gaps between someone's perceived QoL in a domain and how important it is to them (plus prompting reflective questions). However, interventions that are designed to improve QoL may increase the effectiveness of this as optimised behaviour change techniques can be used. This study aims to develop and test a quality of life intervention during social isolation/distancing.

NCT ID: NCT04521634 Completed - Clinical trials for Diabetes Mellitus, Type 1

Glycaemic Variability in Acute Stroke

G-VAS
Start date: September 30, 2020
Phase:
Study type: Observational

Increased glycaemic variability is associated with worse outcome in patients with diabetes after acute stroke.

NCT ID: NCT04521374 Completed - Older Adults Clinical Trials

The Effects of Texture Modified Diets on Dietary Intake and Appetite Responses in Older Adults

Start date: September 7, 2020
Phase: N/A
Study type: Interventional

This study aims to investigate the effects of equicaloric texture modified and regular meals that are either fortified with protein or not on dietary intake and satiety in older adults (65+) living in the United Kingdom (UK).

NCT ID: NCT04519957 Completed - Clinical trials for Treatment Resistant Depression

Long Term Follow Up Study to COMP 001 And COMP 003 Trials (P-TRD LTFU)

Start date: July 20, 2020
Phase:
Study type: Observational

The primary objective of this study is to assess the long-term efficacy of psilocybin with respect to use of new antidepressant treatment, hospitalisations for depression, suicidality, and depressive severity rated using the Montgomery and Asberg Depression Rating Scale (MADRS) over a total of 52 weeks (compared across the 1 mg, 10 mg and 25 mg psilocybin groups from COMP 001).

NCT ID: NCT04519034 Completed - Covid19 Clinical Trials

Vitamin D Status and Immune-inflammatory Status in Different UK Populations With COVID-19 Infection

Start date: September 1, 2020
Phase:
Study type: Observational

Hypothesis: Serum Vitamin D (25(OH)D) is significantly lower in severe versus non-severe COVID-19 infections and that this is a function of ethnicity. There is an association between vitamin D status and various cytokines (pro-inflammatory molecules). The primary objective of this research is to provide a snap shot of vitamin D status in patients from the South-East London area by age, sex, ethnicity and BMI and demonstrate ethnic differences in vitamin D status as well as its associations with severe vs non-severe COVID-19 infections. The secondary objective is to determine if there is an association between vitamin D status and various cytokines (pro-inflammatory molecules) and severity of disease.